Tesla, Inc. (TSLA) Stock Forecast
Data as of May 2, 2026Consumer Cyclical · Current price $391.94 (+2.74%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 29, 2026 | Stephen Gengaro | Stifel Nicolaus | $508.00 | +29.6% |
| Jan 29, 2026 | Joseph Spak | UBS | $352.00 | -10.2% |
| Jan 29, 2026 | George Gianarikas | Canaccord Genuity | $520.00 | +32.7% |
| Jan 29, 2026 | Andrew Percoco | Morgan Stanley | $415.00 | +5.9% |
| Jan 29, 2026 | Vijay Rakesh | Mizuho Securities | $540.00 | +37.8% |
| Jan 23, 2026 | Dan Levy | Barclays | $360.00 | -8.1% |
| Jan 8, 2026 | Alexander Potter | Piper Sandler | $500.00 | +27.6% |
| Jan 2, 2026 | William Stein | Truist Financial | $439.00 | +12.0% |
| Dec 30, 2025 | Ben Kallo | Robert W. Baird | $548.00 | +39.8% |
| Dec 19, 2025 | William Stein | Truist Financial | $444.00 | +13.3% |
| Dec 7, 2025 | Andrew Percoco | Morgan Stanley | $425.00 | +8.4% |
| Nov 25, 2025 | Vijay Rakesh | Mizuho Securities | $475.00 | +21.2% |
| Oct 23, 2025 | William Stein | Truist Financial | $406.00 | +3.6% |
| Oct 21, 2025 | Andres Sheppard | Cantor Fitzgerald | $335.00 | -14.5% |
| Oct 16, 2025 | Dan Levy | Barclays | $350.00 | -10.7% |
| Oct 8, 2025 | Stephen Gengaro | Stifel Nicolaus | $483.00 | +23.2% |
| Oct 6, 2025 | Joseph Spak | UBS | $247.00 | -37.0% |
| Sep 26, 2025 | Edison Yu | Deutsche Bank | $435.00 | +11.0% |
| Sep 26, 2025 | Daniel Ives | Wedbush | $600.00 | +53.1% |
| Sep 5, 2025 | Adam Jonas | Morgan Stanley | $410.00 | +4.6% |
Top Analysts Covering TSLA
TSLA vs Sector & Market
| Metric | TSLA | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.73 | 2.52 | 2.41 |
| Analyst Count | 45 | 13 | 18 |
| Target Upside | +14.9% | +417.5% | +14.9% |
| P/E Ratio | 358.59 | 10.61 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $91.95B | $102.55B | $113.30B | 32 |
| 2027-12-31 | $105.96B | $118.17B | $133.49B | 32 |
| 2028-12-31 | $138.99B | $140.20B | $141.40B | 25 |
| 2029-03-31 | $34.98B | $38.86B | $42.51B | 15 |
| 2029-06-30 | $35.78B | $39.75B | $43.48B | 8 |
| 2029-09-30 | $36.56B | $40.61B | $44.43B | 8 |
| 2029-12-31 | $37.58B | $41.75B | $45.68B | 14 |
| 2030-03-31 | $42.79B | $47.53B | $52.01B | 8 |
| 2030-06-30 | $43.43B | $48.25B | $52.79B | 12 |
| 2030-09-30 | $43.95B | $48.82B | $53.42B | 8 |
| 2030-12-31 | $45.23B | $50.24B | $54.97B | 8 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.07 | $1.93 | $3.01 | 23 |
| 2027-12-31 | $1.33 | $2.48 | $3.37 | 24 |
| 2028-12-31 | $1.48 | $3.33 | $5.59 | 15 |
| 2029-03-31 | $0.93 | $1.06 | $1.19 | 10 |
| 2029-06-30 | $0.93 | $1.07 | $1.20 | 7 |
| 2029-09-30 | $0.92 | $1.06 | $1.18 | 7 |
| 2029-12-31 | $0.90 | $1.03 | $1.15 | 14 |
| 2030-03-31 | $0.00 | $0.00 | $0.00 | 10 |
| 2030-06-30 | $0.00 | $0.00 | $0.00 | 7 |
| 2030-09-30 | $0.00 | $0.00 | $0.00 | 7 |
| 2030-12-31 | $0.00 | $0.00 | $0.00 | 14 |
Frequently Asked Questions
What is the analyst consensus for TSLA?
The consensus among 45 analysts covering Tesla, Inc. (TSLA) is Hold with an average price target of $451.31.
What is the highest price target for TSLA?
The highest price target for TSLA is $600.00, set by Daniel Ives at Wedbush on 2025-09-26.
What is the lowest price target for TSLA?
The lowest price target for TSLA is $85.00, set by Craig Irwin at Roth Capital on 2024-01-25.
How many analysts cover TSLA?
45 analysts have issued ratings for Tesla, Inc. in the past 12 months.
Is TSLA a buy or sell right now?
Based on 45 analyst ratings, TSLA has a consensus rating of Hold (2.73/5) with a +14.9% upside to the consensus target of $451.31.
What are the earnings estimates for TSLA?
Analysts estimate TSLA will report EPS of $1.93 for the period ending 2026-12-31, with revenue estimated at $102.55B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.